Sunder Biomedical Tech. Co., Ltd.
4115
Rank in Stocks
#28132
Sunder Biomedical Tech. Co., Ltd. is engaged in the manufacturing and... Sunder Biomedical Tech. Co., Ltd. is engaged in the manufacturing and distribution of a diverse range of medical devices. Their extensive product portfolio features essential items such as personal protective equipment, including safety goggles and masks crafted from melt-blown nonwoven fabric. The company further provides specialized medical and surgical consumables like suction-irrigation systems, smoke filters, endo bags, and critical supplies for hemodialysis, including blood line sets and A.V. fistula needle sets. Additionally, they offer various intravenous (I.V.) administration apparatus, extension tubes, volume-controlled I.V. sets, surgical tubing kits, standalone components, and transducer protectors. Medical-grade PVC compounds are also among their offerings. Established in 1998, Sunder Biomedical maintains its operational base in Taichung, Taiwan.
Share Price
$0.20363618
Last synced: 2026-11-10
Market Cap
$12.22M
Change (1 day)
-4.16%
Change (1 year)
-26.61%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Sunder Biomedical Tech. Co., Ltd. (4115)
Category
Healthcare
Operating Margin for Sunder Biomedical Tech. Co., Ltd. (4115)
Operating Margin as of November 2026 TTM: 0.53%
According to Sunder Biomedical Tech. Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 0.53%. At the end of 2025 the company had an operating margin of -2.43%.
Operating Margin history for Sunder Biomedical Tech. Co., Ltd. from 2001 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 0.53% | -121.81% |
| 2025 | -2.43% | -177.39% |
| 2024 | 3.14% | -164.61% |
| 2023 | -4.86% | -424.00% |
| 2022 | 1.50% | -78.87% |
| 2021 | 7.10% | 3.50% |
| 2020 | 6.86% | 95.44% |
| 2019 | 3.51% | 67.14% |
| 2018 | 2.10% | 35.48% |
| 2017 | 1.55% | -81.37% |
| 2016 | 8.32% | -16,740.00% |
| 2004 | -0.05% | -109.26% |
| 2003 | 0.54% | -102.43% |
| 2002 | -22.20% | 774.02% |
| 2001 | -2.54% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 28.37% | -46.47% |
US
|
|
| 12.36% | -76.68% |
FR
|
|
| 9.83% | -81.45% |
US
|
|
| 31.11% | -41.30% |
JP
|
|
| 9.87% | -81.38% |
CH
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Sunder Biomedical Tech. Co., Ltd.'s operating margin
What is Sunder Biomedical Tech. Co., Ltd.'s operating margin?
Sunder Biomedical Tech. Co., Ltd.'s operating margin is 0.53%, as of Nov 2026.
What was Sunder Biomedical Tech. Co., Ltd.'s operating margin in 2025?
In 2025, Sunder Biomedical Tech. Co., Ltd.'s operating margin was -2.43%, compared with 3.14% in 2024.
How has Sunder Biomedical Tech. Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, Sunder Biomedical Tech. Co., Ltd.'s operating margin was highest in 2021 (7.10%) and lowest in 2023 (-4.86%).
How does Sunder Biomedical Tech. Co., Ltd.'s operating margin compare with similar companies?
Sunder Biomedical Tech. Co., Ltd.'s operating margin (0.53%) is lower than that of all 5 similar companies listed above. The highest among them is HOYA Corporation, with 31.11%.